… and COVID-19-related hospital admissions by time since vaccination among members of
a large integrated health-care system in the USA up until 6 months after full vaccination. …

… Rituximab has been shown to impair humoral responses for 6 months … therapy around
COVID-19 vaccination will need to be made prior to the availability of data on specific COVID-19 …

… It is possible that some nephrological SPS might be related to the nephrotoxicity of COVID-19
treatment. However, this has been mainly associated with remdesivir [52], which was not …

… to 6 months in patients admitted to hospital with COVID-19. Although there are reports on
outcomes up to 6 months following discharge for patients admitted to hospital with COVID-19 …

… study involving vaccinated health care workers who were tested monthly for the presence of
… the dynamics of antibody levels and to determine predictors of antibody levels at 6 months. …

… However, there still are few data regarding the features of PICS in COVID-19 survivors. …
of COVID-19 ICU survivors. The authors’ aim was to assess QoL of these patients at a six-month …

… treating the acute phase of COVID-19. Recently, persistent COVID-19 symptoms have been
reported up to 3 months … for COVID-19 still complain of one or more symptom 6 months after …

… Previous studies of critically COVID-19 patients have focused … (≥ 6 months) of hospitalized
patients with COVID-19 have … that impact their ability to care for themselves and to perform …

… therapy was provided. At 6 months 70% of patients were still experiencing long COVID-…
While the rate of long COVID-19 symptoms at 6 months seems to be high, it is important to …

… therapy was an exclusion criterion. Participants with a history of Covid-19 were excluded, …
The data in this report show that BNT162b2 prevents Covid-19 effectively for up to 6 months …